Detalhe da pesquisa
1.
A role for adsorption in lead leachability from MSWI bottom ASH.
Waste Manag
; 28(8): 1324-30, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-17881209
2.
Impairment of sodium pump and Na+/H+ antiport in erythrocytes isolated from cancer patients.
Cancer Res
; 56(3): 511-4, 1996 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-8564963
3.
Phosphorus-31 and water proton relaxation in living erythrocytes. Application to uremia.
Biochim Biophys Acta
; 1010(2): 210-7, 1989 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-2912503
4.
Ascorbic acid-2-0-beta-glucuronide, a new metabolite of vitamin C identified in human urine and uremic plasma.
Biochim Biophys Acta
; 1199(3): 305-10, 1994 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-8161570
5.
Inhibition of sodium pump by bepridil. An in vitro and microcalorimetric study.
Biochem Pharmacol
; 44(8): 1529-34, 1992 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-1329768
6.
The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients.
Metabolism
; 49(7): 868-72, 2000 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-10909997
7.
Sodium pump and Na+/H+ activities in uremic erythrocytes. A microcalorimetric and pH-metric study.
Clin Chim Acta
; 259(1-2): 31-40, 1997 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-9086292
8.
Modulation defect of sodium pump evidenced in diabetic patients by a microcalorimetric study.
Clin Chim Acta
; 228(2): 161-70, 1994 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-7988032
9.
A non ouabain-like inhibitor of the sodium pump in uremic plasma ultrafiltrates and urine from healthy subjects.
Clin Chim Acta
; 273(2): 149-60, 1998 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-9657345
10.
Sodium pump and Na+/H+ antiport restoration in erythrocytes from cancer patients in remission.
Oncol Res
; 10(6): 333-9, 1998.
Artigo
em Inglês
| MEDLINE | ID: mdl-9848104
11.
Inhibition of microtubule formation by uremic toxins: action mechanism and hypothesis about the active component.
Clin Nephrol
; 25(4): 212-8, 1986 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-3698354
12.
In vivo accumulation of sodium pump inhibitor by normal and uremic erythrocytes.
Int J Artif Organs
; 16(3): 120-2, 1993 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-8390969
13.
Sodium pump activity in uremic erythrocytes: a microcalorimetric study.
Int J Artif Organs
; 15(3): 135-8, 1992 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-1325947
14.
Kinetic modeling of intracellular pH and comparison with 31P NMR experimental values in dialysed uremic patients.
Int J Artif Organs
; 13(12): 799-802, 1990 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-2289832
15.
Ascorbic acid derivatives in two different fractions of uremic toxins.
Int J Artif Organs
; 14(12): 754-8, 1991 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-1783448
16.
Bioenergetics and DNA alteration of normal human fibroblasts by hexavalent chromium.
Environ Toxicol Pharmacol
; 29(1): 58-63, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21787583
17.
Separation from uremic body fluids and normal urine of Na+, K+-ATPase inhibitor.
Adv Exp Med Biol
; 223: 215-8, 1987.
Artigo
em Inglês
| MEDLINE | ID: mdl-2833847
18.
A possible regulatory system of microtubule formation among uremic toxins.
Adv Exp Med Biol
; 223: 119-23, 1987.
Artigo
em Inglês
| MEDLINE | ID: mdl-3447426
19.
Identification of two uremic toxins by nuclear magnetic resonance and mass spectrometry.
Adv Exp Med Biol
; 223: 223-6, 1987.
Artigo
em Inglês
| MEDLINE | ID: mdl-3447439
20.
A combined analysis of XRCC1, XRCC3, GSTM1 and GSTT1 polymorphisms and centromere content of micronuclei in welders.
Mutagenesis
; 21(2): 159-65, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16551674